News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Miles Gerson,como Presidente Independiente de su Consejo de Administración
Integra Therapeuticsappoints Miles Gerson as Independent Chairman
Corporate
Integra Therapeutics strengthens its corporate governance with the appointment of Miles Gerson as…
Dos científicos trabajando en el laboratorio
Nuage Therapeutics obtains €2.7 million to develop a pioneering treatment against the most aggressive lung cancer
Healthcare
A public-private consortium led by the biotechnology company Nuage Therapeutics, together with the…
Silvia Vanilla y Pedro González, responsables de BePhama Institute
#NewAseBioMember | " AseBio represents a space that raises the collective bar: being a member means contributing and staying accountable"
Healthcare · Corporate
Meet BePharma Institute, our new memeber. We spoke with Pedro Gonzáles Sánchez, manager. 
Foto Joan Puig
Joan Puig: "In inorganic growth in Europe, cultural difference is one of the most important challenges"
Healthcare · Corporate
Joan Puig, a graduate in Pharmacy and in Business Administration and Management, and with a General…
La Inflamación Crónica
Chronic Inflammation: A Key Factor in the Threat to Healthy Aging and Healthy Living
Healthcare
Recent research links persistent inflammatory status to metabolic, neurodegenerative and…
SEDE ORYZON
ORYZON reports financial results and corporate update for quarter ended September 30, 2025
Healthcare · Financing
The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following…
Entrega de los Premios Nacionales de Innovación y de Diseño 2024 a BIOLAN
BIOLAN awarded the 2024 National Innovation Prize, presented by queen Letizia
Talento
The Bizkaia-based biotechnology company received the award at the Royal Palace of El Pardo (Madrid…
20251009 TOVX October Medical Meetings-Spanish
Theriva™ Biologics anuncia varias presentaciones en congresos médicos
Access to innovation
VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 
PreClin VCN-12 Data@ESGCT
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Healthcare
Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a…